Purchase of ANMI PSMA SETRILE 360 VIALS and ANMI ELUTION TOOLS GEN A
The Royal Marsden Hospital requires purchase of ANMI PSMA Setrile 360 VIALS and ANMI Elution Tools Gen A to treat prostate cancer. ANMI PSMA Setrile 360 Vials and ANMI Elution Tools Gen A is the only viable kit for imaging of prostate cancer in UK PMSA-11 is the most specific peptide-chelator available for diagnosis of prostate cancer. No other available treatment as effective are available on the NHS - Ga-68 PSMA scan can be used in PET imaging. PET imaging provides greater resolution and speed of imaging and ther...
Buyer
THE ROYAL MARSDEN NHS FOUNDATION TRUST
Value
£2,200,000
Published
31 May 2019
Closes
26 May 2019
Procurement details
Source
Contracts Finder
Region
Kensington & Chelsea and Hammersmith & Fulham
Procurement method
Other
Category
Goods
Contract starts
31 May 2019
Contract ends
30 May 2021
CPV classifications
33696000
Reagents and contrast media
Lots
Lot default Purchase of ANMI PSMA SETRILE 360 VIALS and ANMI ELUTION TOOLS GEN A
£2,000,000
The Royal Marsden Hospital requires purchase of ANMI PSMA Setrile 360 VIALS and ANMI Elution Tools Gen A to treat prostate cancer. ANMI PSMA Setrile 360 Vials and ANMI Elution Tools Gen A is the only viable kit for imaging of prostate cancer in UK PMSA-11 is the most specific peptide-chelator available for diagnosis of prostate cancer. No other available tre...
Delivery: London · United Kingdom, London, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
31 May 2019
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.